ATE403642T1 - Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE403642T1
ATE403642T1 AT02780917T AT02780917T ATE403642T1 AT E403642 T1 ATE403642 T1 AT E403642T1 AT 02780917 T AT02780917 T AT 02780917T AT 02780917 T AT02780917 T AT 02780917T AT E403642 T1 ATE403642 T1 AT E403642T1
Authority
AT
Austria
Prior art keywords
phenylethanolamine
production
same
pharmaceutical compositions
crystalline form
Prior art date
Application number
AT02780917T
Other languages
English (en)
Inventor
Antoine Caron
Olivier Monnier
Sabrina Obert
Jerome Roche
Isabelle Ziri
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE403642T1 publication Critical patent/ATE403642T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02780917T 2001-06-28 2002-06-27 Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen ATE403642T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108562A FR2826651B1 (fr) 2001-06-28 2001-06-28 Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Publications (1)

Publication Number Publication Date
ATE403642T1 true ATE403642T1 (de) 2008-08-15

Family

ID=8864888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02780917T ATE403642T1 (de) 2001-06-28 2002-06-27 Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (30)

Country Link
US (1) US6992211B2 (de)
EP (1) EP1404641B1 (de)
JP (2) JP4171413B2 (de)
KR (1) KR100869017B1 (de)
CN (1) CN1269797C (de)
AR (1) AR034648A1 (de)
AT (1) ATE403642T1 (de)
AU (1) AU2002333942B2 (de)
BR (1) BR0210661A (de)
CA (1) CA2450213C (de)
CY (1) CY1110099T1 (de)
CZ (1) CZ301450B6 (de)
DE (1) DE60228088D1 (de)
DK (1) DK1404641T3 (de)
EE (1) EE05380B1 (de)
ES (1) ES2307798T3 (de)
FR (1) FR2826651B1 (de)
HK (1) HK1063621A1 (de)
HU (1) HUP0401229A3 (de)
IL (2) IL159134A0 (de)
MX (1) MXPA03011742A (de)
NO (1) NO331169B1 (de)
NZ (1) NZ530140A (de)
PL (1) PL206680B1 (de)
PT (1) PT1404641E (de)
SI (1) SI1404641T1 (de)
SK (1) SK287355B6 (de)
TW (1) TWI286129B (de)
WO (1) WO2003002510A1 (de)
ZA (1) ZA200309512B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant
EP1623705A1 (de) * 2004-07-09 2006-02-08 Sanofi-Aventis Verwendung von Phenyläthanolaminotetralinen zur Herstellung von Anxiolytika
FR2890862B1 (fr) * 2005-09-19 2008-01-25 Sanofi Aventis Sa Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique.
US10280455B2 (en) 2015-12-30 2019-05-07 Bio-Rad Laboratories, Inc. Split-cycle and tape amplification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235103A (en) * 1987-08-12 1993-08-10 Sanofi Process for the preparation of phenylethanolaminotetralins
US5198586A (en) * 1987-08-12 1993-03-30 Sanofi Process for the preparation of phenylethanolaminotetralins
EP0303546B1 (de) * 1987-08-12 1994-12-28 Sanofi Verfahren zur O-Alkylierung von N-(Hydroxy)aralkylphenylethanolamin
US5202466A (en) * 1988-06-14 1993-04-13 Sanofi 2-amino-7-hydroxytetraline ethers
FR2648042B1 (fr) * 1989-06-13 1994-06-10 Midy Spa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments pour le traitement des affections oculaires
FR2643076B1 (fr) * 1989-02-14 1991-06-21 Midy Spa Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
US5312961A (en) * 1989-02-14 1994-05-17 Elf Sanofi 2-amino-7-hydroxytetralin carboxylalkyl ethers
FR2669821A1 (fr) * 1990-12-04 1992-06-05 Sanofi Sa Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression.
FR2826651B1 (fr) * 2001-06-28 2005-09-02 Sanofi Synthelabo Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant

Also Published As

Publication number Publication date
NO20035839L (no) 2004-03-01
SK15932003A3 (sk) 2004-05-04
EP1404641A1 (de) 2004-04-07
HUP0401229A3 (en) 2008-03-28
SI1404641T1 (sl) 2008-10-31
PL368055A1 (en) 2005-03-21
CZ301450B6 (cs) 2010-03-03
JP2004530725A (ja) 2004-10-07
CA2450213A1 (en) 2003-01-09
BR0210661A (pt) 2004-10-05
AU2002333942B2 (en) 2008-02-28
NZ530140A (en) 2005-05-27
US6992211B2 (en) 2006-01-31
CY1110099T1 (el) 2015-01-14
CA2450213C (en) 2011-02-15
CN1522241A (zh) 2004-08-18
FR2826651B1 (fr) 2005-09-02
HK1063621A1 (en) 2005-01-07
IL159134A0 (en) 2004-05-12
JP4799592B2 (ja) 2011-10-26
KR20040017817A (ko) 2004-02-27
ES2307798T3 (es) 2008-12-01
TWI286129B (en) 2007-09-01
DK1404641T3 (da) 2008-12-08
PL206680B1 (pl) 2010-09-30
JP2009029804A (ja) 2009-02-12
JP4171413B2 (ja) 2008-10-22
DE60228088D1 (de) 2008-09-18
PT1404641E (pt) 2008-09-22
IL159134A (en) 2009-07-20
US20040180953A1 (en) 2004-09-16
SK287355B6 (sk) 2010-08-09
FR2826651A1 (fr) 2003-01-03
AR034648A1 (es) 2004-03-03
EE05380B1 (et) 2011-02-15
EP1404641B1 (de) 2008-08-06
NO331169B1 (no) 2011-10-24
CZ20033531A3 (en) 2004-04-14
ZA200309512B (en) 2004-12-08
KR100869017B1 (ko) 2008-11-17
HUP0401229A2 (hu) 2004-10-28
WO2003002510A1 (fr) 2003-01-09
MXPA03011742A (es) 2004-07-01
CN1269797C (zh) 2006-08-16
EE200400007A (et) 2004-02-16

Similar Documents

Publication Publication Date Title
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
DE69928260D1 (de) Schwefel-substituierte sulfonylaminocarbonsäure n-arylamide, ihre herstellung, ihre anwendung und diese enthaltende pharmazeutische zusammensetzungen
DE60001546D1 (de) Liponsaürederivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
DE50313653D1 (de) Wasserlösliche eisen-kohlenhydrat-komplexe, deren herstellung und diese enthaltende arzneimittel
IL220888A0 (en) 3,10 and 12 a substituted tetracyline compounds, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
DE60318188D1 (de) Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
ATE432919T1 (de) Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
HUP0402047A3 (en) 7,9-substituted tetracycline compounds, their use and pharmaceutical compositions containing them
DE60122567D1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
DE60219051D1 (de) Pyrimidonverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
JP2005509503A5 (de)
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
EP1509220A4 (de) Pharmazeutische zusammensetzung zur behandlung von seborrhoe mit 4-hydroxy-5-methoxy-4-2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl -1-oxaspiro 2,5 octan-6-on
DE69610085D1 (de) Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATE403642T1 (de) Kristalline form eines phenylethanolamins, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE290543T1 (de) Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404641

Country of ref document: EP